One proposed mechanism for this phenomenon is paracrine activation of EGFR on non-transformed epithelia via tumor-derived EGFR ligands [35], and the elevated expression of Areg and Ereg transcripts in GLI2A-expressing tumors (Figure 4) is in keeping with this possibility. The gene discussed is EGFR; the disease is neoplasm.